The
Pharmacogenomics and Nanobiotechnology group at Akhuwat FIRST is led by Tehreem
Hayat and focuses on two research areas.
PHARMACOGENOMICS
Pharmacogenomics
is basically the applicability of genomics to drug development. Major objectives
are,
To
establish genotypes of patients and penetrance of a particular genotype in our
population.
To
search for potential biomarkers for treatment responses in different chronic
infections.
To
use the information of genetic variations, present among individuals in the
discovery and development of more effective therapeutic agents.
The
use of molecular profiling techniques for proper decision making in the choice
of therapeutic strategy for the right person at the right time and delivering
timely prevention at population level.
2. NANOBIOTECHNOLOGY
Currently, we are more focused on green
nanobiotechnology. Major objectives are;
Synthesis
of oxide nanoparticles using green approaches.
Characterization
of green nanoparticles using UV visible spectroscopy, FTIR, X-ray Diffraction,
Dynamic Light Scattering, TEM and SEM.
Measurement
of antimicrobial activities of these NPs.
Establishment
of protocols for use of green nanoparticles in industries.
Join the conversation
Social Butterfly? Join the conversation on our social media pages, get the lowdown on campus life and see the impact of research carried out by our academics and students.